DrugDashboards

Market view

dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride · Suspension

4 marketed package NDCs · 3 active manufacturers

Most dispensed: 18 mg/15mL; 200 mg/15mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/15mL · Liquid · #240 mL/bottle · 20 mg/20mL; 400 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL · Liquid · #180 mL/bottle, plastic · 5 mg/5mL; 100 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/5mL · Solution · #1 bottle/carton / 118 ml in 1 bottle · 5 mg/5mL; 100 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/5mL · Suspension · #1 bottle/carton / 118 ml in 1 bottle

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr exited
    Pharmadel LLC · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Mfr exited
    Pharmadel LLC · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Genomma Lab USA · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Menper Distributors, Inc. · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Mfr exited
    Menper Distributors, Inc. · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Mfr entered
    Pharmadel LLC · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Broncomiel AdultsAug 26, 2026
    Mfr entered
    Pharmadel LLC · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Mfr entered
    Genomma Lab USA · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Menper Distributors, Inc. · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
  • Mfr entered
    Menper Distributors, Inc. · dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride in shortage right now?
No. FDA does not currently list Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride?
19 companies have marketed Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride cost?
The typical pharmacy pays about $0.0700 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.